Noordermeer, Siri D. S.
Luman, Marjolein
Weeda, Wouter D.
Buitelaar, Jan K.
Richards, Jennifer S.
Hartman, Catharina A.
Hoekstra, Pieter J.
Franke, Barbara
Heslenfeld, Dirk J.
Oosterlaan, Jaap
Funding for this research was provided by:
National Institutes of Health (R01MH62873)
NWO Investment Grant (1750102007010)
NWO Brain and Cognition (056 24 011)
European Union 7th Framework programs AGGRESSOTYPE (602805)
Radboud University Medical Center
Universitair Medisch Centrum Groningen
Accare
Vrije Universiteit Amsterdam
Article History
Received: 31 August 2016
Accepted: 3 March 2017
First Online: 10 March 2017
Compliance with ethical standards
:
: Jan K. Buitelaar has been a consultant to/member of advisory board of and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Medice, Shire, Roche, and Servier in the past 3 years. He is neither an employee nor a stock shareholder of any of these companies, and has no other financial or material support, including expert testimony, patents, or royalties. Barbara Franke received an educational speaking fee from Merz. Pieter J. Hoekstra has been a consultant to/member of advisory board for Shire in the past 3 years. Siri D.S. Noordermeer, Marjolein Luman, Wouter D. Weeda, Jennifer S. Richards, Catharina A. Hartman, Dirk J. Heslenfeld and Jaap Oosterlaan report no financial interests or potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.